Leveraging Adeno-Associated Viruses (AAVs) in therapeutic approaches for monogenic neurological diseases

Supplied by PerkinElmer on Wednesday, 07 September, 2022

Within the field of neurological diseases, there is great interest in looking at rare diseases of monogenic origin with the hope of developing disease-modifying gene therapies, as opposed to treatments for symptom management. Therefore, using relatively tunable systems like recombinant AAVs, scientists are also exploring in vivo gene delivery in parallel to ex vivo.

Learn about key strategies and innovations in this space that are enabling advanced gene therapy.

DOWNLOAD

5 Pages PDF

Related White Papers

Key insights into the diversity of immune cells and signalling pathways

This whitepaper provides you with critical...

DNA/RNA extraction from formalin fixed paraffin embedded tissue samples

To find out about an automation-friendly process for extracting total nucleic acid from...

Limit your risk, avoid waste and ensure compliance to government legislation

This paper provides an overview of the importance...

Content from other channels on our network

Fiona Stanley Hospital, ECU team up to reduce ICU noise

Fast track for internationally trained medical specialists

Severe mental illness and physical ailments: what's the link?

General use items decision welcomed by the industry

Why Addressing Transparency Concerns in Healthcare Supply Chains is More Urgent Than Ever

ABS data: cautious consumers opt for home cooking

Why you can taste more ethanol in a cold beer

NZ Food Safety reports on food recalls in 2023

Pact Group wins Circular Economy Award for milk bottle recycling efforts

SCT starts construction of refrigeration facility in WA

Aspen Technology introduces CCUS planning solution

LAPP industrial remote solutions focus on secure remote maintenance and network integration

Reducing emissions from industrial processes by effective particulate monitoring

US researchers looking at extracting hydrogen from rocks

New facility turns plastic waste into low-carbon building materials